Inventor
BHATTI BALWINDER SINGH
US32 patents
⚠️ This page may combine multiple inventors who share the name “BHATTI BALWINDER SINGH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TARGACEPT INC
18 patentsUS6455554B1Sep 24, 2002
Oxopyridinyl pharmaceutical compositions and methods for use
TARGACEPT INC77 citations94
US6958399B2Oct 25, 2005
Compounds capable of activating cholinergic receptors
TARGACEPT INC28 citations92
US6624173B1Sep 23, 2003
Pharmaceutical compositions for treating and/or preventing CNS disorders
TARGACEPT INC39 citations92
US6417359B1Jul 9, 2002
Pharmaceutical compositions and methods for use
TARGACEPT INC33 citations92
US6337351B1Jan 8, 2002
Pharmaceutical compositions and methods for use
TARGACEPT INC32 citations92
US6310102B1Oct 30, 2001
Pharmaceutical compositions and methods for use
TARGACEPT INC27 citations92
US9145396B2Sep 29, 2015
Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3ylvinyl)pyrimidine
TARGACEPT INC16 citations90
US7897611B2Mar 1, 2011
Pharmaceutical compositions and methods for relieving pain and treating central nervous system disorders
TARGACEPT INC10 citations82
US7307092B2Dec 11, 2007
Compounds Capable of Activating Cholinergic Receptors
TARGACEPT INC9 citations73
US7060826B2Jun 13, 2006
Compounds capable of activating cholinergic receptors
TARGACEPT INC10 citations73
US9532974B2Jan 3, 2017
Nicotinic receptor non-competitive antagonists
TARGACEPT INC2 citations71
US6624167B1Sep 23, 2003
Pharmaceutical compositions and methods for use
TARGACEPT INC11 citations71
US6627648B1Sep 30, 2003
Pharmaceutical compositions and methods for use
TARGACEPT INC9 citations68
US6890935B2May 10, 2005
Pharmaceutical compositions and methods for use
TARGACEPT INC2 citations63
US6579878B1Jun 17, 2003
Pharmaceutical compositions and methods for use
TARGACEPT INC5 citations61
US7101896B2Sep 5, 2006
Pharmaceutical compositions and methods for use
TARGACEPT INC0 citations52
US7790757B2Sep 7, 2010
Compounds capable of activating cholinergic receptors
TARGACEPT INC0 citations51
US7022706B2Apr 4, 2006
Pharmaceutical compositions and methods for use
TARGACEPT INC0 citations50
OYSTER POINT PHARMA INC
4 patentsUS10421745B2Sep 24, 2019
Salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine
OYSTER POINT PHARMA INC10 citations91
US11542253B2Jan 3, 2023
Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine
OYSTER POINT PHARMA INC6 citations84
US10919879B2Feb 16, 2021
Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine
OYSTER POINT PHARMA INC7 citations83
US9981949B2May 29, 2018
Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine
OYSTER POINT PHARMA INC8 citations83
AKIREDDY SRINIVASA RAO
4 patentsUS8604191B2Dec 10, 2013
Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3YLVINYL)pyrimidine
AKIREDDY SRINIVASA RAO12 citations82
US8153821B2Apr 10, 2012
Compounds
AKIREDDY SRINIVASA RAO9 citations82
US8809397B2Aug 19, 2014
Nicotinic receptor non-competitive antagonists
AKIREDDY SRINIVASA RAO5 citations81
US8802694B2Aug 12, 2014
3,6-diazabicyclo[3.1.1]heptanes as neuronal nicotinic acetycholine receptor ligands
AKIREDDY SRINIVASA RAO1 citations48
(unassigned)
3 patentsUS5726316AMar 10, 1998
Pharmaceutical compositions for prevention and treatment of central nervous system disorders
98 citations96
US6262124B1Jul 17, 2001
Pharmaceutical compositions and methods for use
22 citations92
US6057446AMay 2, 2000
Certain 1-aza-tricyclo [3.3.1-13,7 ] decane compounds
20 citations92